TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Form Specific Drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Form Specific Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Form Specific Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Form Specific Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Form Specific Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Form Specific Drugs industry

Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEJul 23, 2025ARROWHOUSE
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAJul 23, 2025KELTIE
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEJul 22, 2025BIONTECH
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEJul 15, 2025MODERNATX
Anticancer CompositionsARAGON PHARMACEUTICALSJul 9, 2025EIP
Nucleic Acid VaccinesMODERNATXJul 9, 2025BIONTECH
Nucleic Acid VaccinesMODERNATXJul 9, 2025BIONTECH
Anticancer CompositionsARAGON PHARMACEUTICALSJul 8, 2025TEVA PHARMACEUTICALS
Anticancer CompositionsARAGON PHARMACEUTICALSJul 7, 2025ZENTIVA KS
Nucleic Acid VaccinesMODERNATXJul 4, 2025PFIZER

To stay ahead in the competitive Form Specific Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Form Specific Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
Nov 13, 2019Apixaban FormulationsPFIZER12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN11
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
Oct 16, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND10
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS10
Nov 27, 2019Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGEN10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNATX10